|
[1]
|
Pérez Palmer, N., Trejo Ortega, B. and Joshi, P. (2022) Cognitive Impairment in Older Adults: Epidemiology, Diagnosis, and Treatment. Psychiatric Clinics of North America, 45, 639-661.
https://doi.org/10.1016/j.psc.2022.07.010
|
|
[2]
|
Jongsiriyanyong, S. and Limpawattana, P. (2018) Mild Cognitive Impairment in Clinical Practice: A Review Article. American Journal of Alzheimer’s Disease & Other Dementias, 33, 500-507.
https://doi.org/10.1177/1533317518791401
|
|
[3]
|
Javitt, D.C. (2023) Cognitive Impairment Associated with Schizophrenia: From Pathophysiology to Treatment. Annual Review of Pharmacology and Toxicology, 63, 119-141.
https://doi.org/10.1146/annurev-pharmtox-051921-093250
|
|
[4]
|
Degirmenci, Y., Angelopoulou, E., Georgakopoulou, V.E. and Bougea, A. (2023) Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches. Medicina, 59, Article 1756.
https://doi.org/10.3390/medicina59101756
|
|
[5]
|
Bianchi, V.E., Herrera, P.F. and Laura, R. (2021) Effect of Nutrition on Neurodegenerative Diseases. A Systematic Review. Nutritional Neuroscience, 24, 810-834.
https://doi.org/10.1080/1028415x.2019.1681088
|
|
[6]
|
Zhang, D., Zhang, W., Ming, C., Gao, X., Yuan, H., Lin, X., et al. (2024) P-Tau217 Correlates with Neurodegeneration in Alzheimer’s Disease, and Targeting P-Tau217 with Immunotherapy Ameliorates Murine Tauopathy. Neuron, 112, 1676-1693.e12.
https://doi.org/10.1016/j.neuron.2024.02.017
|
|
[7]
|
Raulin, A.C., Doss, S.V., Trottier, Z.A., et al. (2022) ApoE in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies. Molecular Neurodegeneration, 17, Article No. 72.
https://doi.org/10.1186/s13024-022-00574-4
|
|
[8]
|
Rump, K. and Adamzik, M. (2022) Epigenetic Mechanisms of Postoperative Cognitive Impairment Induced by Anesthesia and Neuroinflammation. Cells, 11, Article 2954.
https://doi.org/10.3390/cells11192954
|
|
[9]
|
Wang, Y., Lin, Y., Wang, L., et al. (2020) TREM2 Ameliorates Neuroinflammatory Response and Cognitive Impairment via PI3K/AKT/FoxO3a Signaling Pathway in Alzheimer’s Disease Mice. Aging, 12, 20862-20879.
https://doi.org/10.18632/aging.104104
|
|
[10]
|
Wei, X., Zhang, F., Cheng, D., Wang, Z., Xing, N., Yuan, J., et al. (2024) Free Heme Induces Neuroinflammation and Cognitive Impairment by Microglial Activation via the TLR4/MyD88/NF-κB Signaling Pathway. Cell Communication and Signaling, 22, Article No. 16.
https://doi.org/10.1186/s12964-023-01387-8
|
|
[11]
|
Jin, X., Liu, M.Y., Zhang, D.F., et al. (2019) Baicalin Mitigates Cognitive Impairment and Protects Neurons from Microglia‐Mediated Neuroinflammation via Suppressing NLRP3 Inflammasomes and TLR4/NF‐κB Signaling Pathway. CNS Neuroscience & Therapeutics, 25, 575-590.
https://doi.org/10.1111/cns.13086
|
|
[12]
|
Pink, A., Krell‐Roesch, J., Syrjanen, J.A., Vassilaki, M., Lowe, V.J., Vemuri, P., et al. (2022) A Longitudinal Investigation of Aβ, Anxiety, Depression, and Mild Cognitive Impairment. Alzheimer’s & Dementia, 18, 1824-1831.
https://doi.org/10.1002/alz.12504
|
|
[13]
|
张国玲, 汪迪, 赵洁, 周玲. 舒肝解郁胶囊联合丙戊酸钠治疗双相情感障碍的效果及其对患者认知功能、神经递质的影响[J]. 大医生, 2025, 10(19): 13-15.
|
|
[14]
|
Lim, A.W.Y., Schneider, L. and Loy, C. (2024) Galantamine for Dementia Due to Alzheimer’s Disease and Mild Cognitive Impairment. Cochrane Database of Systematic Reviews, 2024, CD001747.
https://doi.org/10.1002/14651858.cd001747.pub4
|
|
[15]
|
Lin, C.H., Huang, Y.J., Lin, C.J., et al. (2014) NMDA Neurotransmission Dysfunction in Mild Cognitive Impairment and Alzheimer’s Disease. Current Pharmaceutical Design, 20, 5169-5179.
https://doi.org/10.2174/1381612819666140110115603
|
|
[16]
|
Greene, C., Connolly, R., Brennan, D., Laffan, A., O’Keeffe, E., Zaporojan, L., et al. (2024) Blood-Brain Barrier Disruption and Sustained Systemic Inflammation in Individuals with Long COVID-Associated Cognitive Impairment. Nature Neuroscience, 27, 421-432.
https://doi.org/10.1038/s41593-024-01576-9
|
|
[17]
|
Ishikawa, K., Yamamoto, S., Hattori, S., Nishimura, N., Matsumoto, H., Miyakawa, T., et al. (2021) Neuronal Degeneration and Cognitive Impairment Can Be Prevented via the Normalization of Mitochondrial Dynamics. Pharmacological Research, 163, Article 105246.
https://doi.org/10.1016/j.phrs.2020.105246
|
|
[18]
|
林茵如, 陈弼沧, 吴秋英, 杨源杰. T2DM认知障碍国内外研究进展[J]. 糖尿病新世界, 2025, 28(3): 185-187+191.
|
|
[19]
|
陈雕, 陈永鑫, 王贵婷, 等. 糖脂代谢紊乱对糖尿病小鼠认知功能的影响及其机制[J]. 贵州医科大学学报, 2025, 50(10): 1466-1473.
|
|
[20]
|
Kinsley, K. and Pritchett, W. (2023) Chemotherapy-Induced Cognitive Impairment. The Clinical Journal of Oncology Nursing, 27, 205-208.
|
|
[21]
|
Belrose, J.C. and Noppens, R.R. (2019) Anesthesiology and Cognitive Impairment: A Narrative Review of Current Clinical Literature. BMC Anesthesiology, 19, Article No. 241.
https://doi.org/10.1186/s12871-019-0903-7
|
|
[22]
|
Zhang, N. and Gordon, M.L. (2018) Clinical Efficacy and Safety of Donepezil in the Treatment of Alzheimer’s Disease in Chinese Patients. Clinical Interventions in Aging, 13, 1963-1970.
https://doi.org/10.2147/cia.s159920
|
|
[23]
|
DeBattista, C. and Schatzberg, A.F. (2024) The Black Book of Psychotropic Dosing and Monitoring. Psychopharmacology Bulletin, 54, 8-59.
https://doi.org/10.64719/pb.4493
|
|
[24]
|
Morgan, A., Li, Y., Thompson, N.R., Milinovich, A., Abbatemarco, J.R., Cohen, J.A., et al. (2024) Longitudinal Disability, Cognitive Impairment, and Mood Symptoms in Patients with Anti-NMDA Receptor Encephalitis. Neurology, 102, e208019.
https://doi.org/10.1212/wnl.0000000000208019
|
|
[25]
|
Howard, R., McShane, R., Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., et al. (2012) Donepezil and Memantine for Moderate-to-Severe Alzheimer’s Disease. New England Journal of Medicine, 366, 893-903.
https://doi.org/10.1056/nejmoa1106668
|
|
[26]
|
Brown, P.D., Pugh, S., Laack, N.N., Wefel, J.S., Khuntia, D., Meyers, C., et al. (2013) Memantine for the Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled Trial. Neuro-Oncology, 15, 1429-1437.
https://doi.org/10.1093/neuonc/not114
|
|
[27]
|
Alexander, G.C., Emerson, S. and Kesselheim, A.S. (2021) Evaluation of Aducanumab for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility. Journal of the American Medical Association, 325, 1717-1718.
https://doi.org/10.1001/jama.2021.3854
|
|
[28]
|
Kim, J., Lee, H., Park, J., Cha, B. and Hoe, H. (2022) Nilotinib Modulates LPS-Induced Cognitive Impairment and Neuroinflammatory Responses by Regulating P38/STAT3 Signaling. Journal of Neuroinflammation, 19, Article No. 187.
https://doi.org/10.1186/s12974-022-02549-0
|
|
[29]
|
Ma, J., Wang, R., Chen, Y., Wang, Z. and Dong, Y. (2023) 5-HT Attenuates Chronic Stress-Induced Cognitive Impairment in Mice through Intestinal Flora Disruption. Journal of Neuroinflammation, 20, Article No. 23.
https://doi.org/10.1186/s12974-023-02693-1
|
|
[30]
|
Hong, C., Wang, Z., Zheng, S., Hu, W., Wang, S., Zhao, Y., et al. (2022) Metrnl Regulates Cognitive Dysfunction and Hippocampal BDNF Levels in D-Galactose-Induced Aging Mice. Acta Pharmacologica Sinica, 44, 741-751.
https://doi.org/10.1038/s41401-022-01009-y
|
|
[31]
|
Hu, W., Zou, L., Yu, N., Wu, Z., Yang, W., Wu, T., et al. (2024) Catalpol Rescues LPS-Induced Cognitive Impairment via Inhibition of NF-κB-Regulated Neuroinflammation and Up-Regulation of TrkB-Mediated BDNF Secretion in Mice. Journal of Ethnopharmacology, 319, Article 117345.
https://doi.org/10.1016/j.jep.2023.117345
|
|
[32]
|
Chen, X., Chen, A., Wei, J., Huang, Y., Deng, J., Chen, P., et al. (2023) Dexmedetomidine Alleviates Cognitive Impairment by Promoting Hippocampal Neurogenesis via BDNF/TrkB/CREB Signaling Pathway in Hypoxic-Ischemic Neonatal Rats. CNS Neuroscience & Therapeutics, 30, e14486.
https://doi.org/10.1111/cns.14486
|
|
[33]
|
Kong, X., Lyu, W., Lin, X., Lin, C., Feng, H., Xu, L., et al. (2024) Itaconate Alleviates Anesthesia/Surgery-Induced Cognitive Impairment by Activating a Nrf2-Dependent Anti-Neuroinflammation and Neurogenesis via Gut-Brain Axis. Journal of Neuroinflammation, 21, Article No. 104.
https://doi.org/10.1186/s12974-024-03103-w
|
|
[34]
|
Yang, Z.J., Huang, S.Y., Zhong, K.Y., et al. (2024) Betaine Alleviates Cognitive Impairment Induced by Homocysteine through Attenuating NLRP3-Mediated Microglial Pyroptosis in an m(6)A-YTHDF2-Dependent Manner. Redox Biology, 69, Article 103026.
https://doi.org/10.1016/j.redox.2024.103026
|
|
[35]
|
Zhao, Z., Zhang, J., Wu, Y., Xie, M., Tao, S., Lv, Q., et al. (2024) Plasma IL-6 Levels and Their Association with Brain Health and Dementia Risk: A Population-Based Cohort Study. Brain, Behavior, and Immunity, 120, 430-438.
https://doi.org/10.1016/j.bbi.2024.06.014
|
|
[36]
|
Soni, N., Kar, I., Narendrasinh, J.D., Shah, S.K., Konathala, L., Mohamed, N., et al. (2024) Role and Application of CRISPR-Cas9 in the Management of Alzheimer’s Disease. Annals of Medicine & Surgery, 86, 1517-1521.
https://doi.org/10.1097/ms9.0000000000001692
|
|
[37]
|
Liang, Y., Kang, X., Zhang, H., Xu, H. and Wu, X. (2023) Knockdown and Inhibition of Hippocampal GPR17 Attenuates Lipopolysaccharide-Induced Cognitive Impairment in Mice. Journal of Neuroinflammation, 20, Article No. 271.
https://doi.org/10.1186/s12974-023-02958-9
|
|
[38]
|
Chen, F., Fang, S., Du, Y., Ghosh, A., Reed, M.N., Long, Y., et al. (2021) CRISPR/Cas9-Mediated CysLT1R Deletion Reverses Synaptic Failure, Amyloidosis and Cognitive Impairment in APP/PS1 Mice. Aging, 13, 6634-6661.
https://doi.org/10.18632/aging.202501
|
|
[39]
|
Wang, Y., Wang, Y., Bharti, V., Zhou, H., Hoi, V., Tan, H., et al. (2019) Upregulation of Thioredoxin-Interacting Protein in Brain of Amyloid-β Protein Precursor/Presenilin 1 Transgenic Mice and Amyloid-β Treated Neuronal Cells. Journal of Alzheimer’s Disease, 72, 139-150.
https://doi.org/10.3233/jad-190223
|
|
[40]
|
Xiong, Y., Liang, W., Wang, X., Zhu, H., Yi, P., Wei, G., et al. (2024) S100A8 Knockdown Activates the PI3K/AKT Signaling Pathway to Inhibit Microglial Autophagy and Improve Cognitive Impairment Mediated by Chronic Sleep Deprivation. International Immunopharmacology, 143, Article 113375.
https://doi.org/10.1016/j.intimp.2024.113375
|
|
[41]
|
Liu, Z. and Cheung, H.H. (2020) Stem Cell-Based Therapies for Parkinson Disease. International Journal of Molecular Sciences, 21, Article 8060.
https://doi.org/10.3390/ijms21218060
|
|
[42]
|
Wang, X., Ma, S., Yang, B., Huang, T., Meng, N., Xu, L., et al. (2018) Resveratrol Promotes hUC-MSCs Engraftment and Neural Repair in a Mouse Model of Alzheimer’s Disease. Behavioural Brain Research, 339, 297-304.
https://doi.org/10.1016/j.bbr.2017.10.032
|
|
[43]
|
Liu, Z., Wang, C., Wang, X. and Xu, S. (2015) Therapeutic Effects of Transplantation of As-MiR-937-Expressing Mesenchymal Stem Cells in Murine Model of Alzheimer’s Disease. Cellular Physiology and Biochemistry, 37, 321-330.
https://doi.org/10.1159/000430356
|
|
[44]
|
Nasiri, E., Alizadeh, A., Roushandeh, A.M., Gazor, R., Hashemi-Firouzi, N. and Golipoor, Z. (2019) Melatonin-Pretreated Adipose-Derived Mesenchymal Stem Cells Efficeintly Improved Learning, Memory, and Cognition in an Animal Model of Alzheimer’s Disease. Metabolic Brain Disease, 34, 1131-1143.
https://doi.org/10.1007/s11011-019-00421-4
|
|
[45]
|
Sauder, C., Allen, L.A., Baker, E., Miller, A.C., Paul, S.M. and Brannan, S.K. (2022) Effectiveness of KarXT (Xanomeline-Trospium) for Cognitive Impairment in Schizophrenia: Post Hoc Analyses from a Randomised, Double-Blind, Placebo-Controlled Phase 2 Study. Translational Psychiatry, 12, Article No. 491.
https://doi.org/10.1038/s41398-022-02254-9
|
|
[46]
|
Zhou, L., Shi, H., Xiao, M., Liu, W., Wang, L., Zhou, S., et al. (2025) Remimazolam Attenuates Lipopolysaccharide-Induced Neuroinflammation and Cognitive Dysfunction. Behavioural Brain Research, 476, Article 115268.
https://doi.org/10.1016/j.bbr.2024.115268
|